fda guidelines for tirzepatide is NO longer in SHORTAGE. What You Need to Know Oral Tirzepatide Pill: FDA Status

GLP-1RA should be used as a drug of choice in patients with overweight and obesity with comorbid MetS, pre-diabetes, type 2 diabetes mellitus, hypertension, atherosclerosis and its clinical sequelae such as OSA, fatty liver disease and polycystic ovary syndrome

Your provider should assess baseline GI symptoms, establish a slower titration schedule, and monitor for new or worsening bloating, diarrhea, or abdominal pain at each dose increase

Our Patient Safety Promise Patient safety is the cornerstone of our care

doi:10.3390/cimb46120872

Vasyukova et al., 2023

But the actual research, there is a a well-known meta-analysis on this, found that once you account for total daily protein, there is no magic anabolic window